Annual Drug Patent Expirations for LIVMARLI
Livmarli is a drug marketed by Mirum and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has one hundred and ten patent family members in twenty-one countries.
The generic ingredient in LIVMARLI is maralixibat chloride. One supplier is listed for this compound. Additional details are available on the maralixibat chloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
